Table 2.
Pass rate versus IMRT technique, treatment planning system, linear accelerator manufacturer, and linac-TPS combination.
| Criterion failed |
|||||
|---|---|---|---|---|---|
| Pass rate (%) | Attempts | Dose | DTA | Dose and DTA | |
| IMRT technique | |||||
| Dynamic MLC | 88 | 296 | 26 | 5 | 5 |
| IMAT | 86 | 103 | 11 | 0 | 3 |
| Segmental | 76 | 634 | 109 | 15 | 25 |
| Solid attenuator | 43 | 7 | 4 | 0 | 0 |
| TomoTherapy |
93 |
99 |
6 |
1 |
0 |
| Treatment planning system | |||||
| Eclipse | 88 | 387 | 30 | 8 | 7 |
| Pinnacle3 | 75 | 425 | 84 | 8 | 13 |
| TomoTherapy | 93 | 99 | 6 | 1 | 0 |
| XiO | 76 | 137 | 19 | 4 | 10 |
| Other |
78 |
91 |
17 |
0 |
3 |
| Linear accelerator manufacturer | |||||
| Elekta | 67 | 130 | 37 | 4 | 2 |
| Siemens | 70 | 135 | 32 | 3 | 6 |
| TomoTherapy | 93 | 99 | 6 | 1 | 0 |
| Varian |
85 |
775 |
81 |
13 |
25 |
| Linac-TPS combination | |||||
| Elekta-Pinnacle3 | 66 | 90 | 28 | 3 | 0 |
| Siemens-Pinnacle3 | 67 | 76 | 21 | 0 | 4 |
| TomoTherapy-HiArt | 93 | 99 | 6 | 1 | 0 |
| Varian-Eclipse | 90 | 372 | 22 | 7 | 7 |
| Varian-Pinnacle3 | 81 | 267 | 38 | 5 | 9 |
| Varian-XiO | 77 | 74 | 10 | 1 | 6 |